Skip to main content

4 Result(s)

within Christopher G. Willett Remove this filter Biomedicine, general Remove this filter

and

  1. No Access

    Article

    Does adjuvant chemoradiation benefit patients who have undergone resection of pancreatic or periampullary cancer?

    Christopher G Willett, Brian G Czito in Nature Clinical Practice Gastroenterology … (2008)

  2. Article

    Reply to “PET concerns in bevacizumab treatment”

    Christopher G Willett, Daniel Duda, Alan Fischman, Rakesh K Jain in Nature Medicine (2004)

    Download PDF (211 KB) View Article

  3. Article

    Correction: Corrigendum: Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer

    Nat. Med. 10, 145–147 (2004). The complete trial schema was omitted from the article. The protocol is outlined below. Table 1.

    Christopher G Willett, Yves Boucher, Emmanuelle di Tomaso, Dan G Duda… in Nature Medicine (2004)

    Download PDF (65 KB) View Article

  4. No Access

    Article

    Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer

    The effects of vascular endothelial growth factor (VEGF) blockade on the vascular biology of human tumors are not known. Here we show here that a single infusion of the VEGF-specific antibody bevacizumab decre...

    Christopher G Willett, Yves Boucher, Emmanuelle di Tomaso, Dan G Duda… in Nature Medicine (2004)